Karolinska Development AB (publ) functions as a venture capital firm, dedicating its capital to companies across various development stages, including seed, early, and growth phases. The company's investment strategy concentrates on a broad spectrum of life science and healthcare sectors, such as pharmaceutical and medical research and development, healthcare technology, gene research, advanced drug delivery solutions, biotechnology, and life science tools and services. Geographically, the firm prioritizes the Nordic region, specifically seeking opportunities within Sweden, Iceland, Norway, Finland, and Denmark. While it primarily aims to be the principal investor in its portfolio companies, it also considers collaborative investments. On an annual basis, Karolinska Development AB (publ) targets engaging in up to five new projects. The company was established in 2003 and is headquartered in Stockholm, Sweden.
Check out other names from the same Biotechnology industry as KDEV.ST.